You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enhancer of zeste homolog 2 (EZH2) inhibition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

Recruiting
  • Peripheral Nerve Sheath Tumor
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma Trial in Worldwide (Valemetostat Tosylate)

Recruiting
  • Relapsed/Refractory Peripheral T-Cell Lymphoma
  • Adult T Cell Leukemia/Lymphoma
  • Valemetostat Tosylate
  • Duarte, California
  • +59 more
Jun 3, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

Non Small Cell Lung Cancer Trial in West Los Angeles (Tazemetostat)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • West Los Angeles, California
    VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Jul 21, 2022

Solid Tumor, Lymphoma Trial in Beijing (SHR2554+SHR1701, SHR1701)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
Sep 22, 2020

B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2) Trial in Worldwide

Completed
  • B-cell Lymphomas (Phase 1)
  • +5 more
  • Birmingham, Alabama
  • +51 more
Dec 8, 2021

B-Cell Lymphoma Trial in United States (CPI-1205)

Completed
  • B-Cell Lymphoma
  • Lafayette, Indiana
  • +5 more
May 16, 2022

Prostate Cancer Trial in Los Angeles (Tazverik)

Not yet recruiting
  • Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 30, 2022

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

T-cell Lymphoma, CLL/SLL Trial in Birmingham (Tazemetostat, Acalabrutinib and Tazemetostat)

Not yet recruiting
  • T-cell Lymphoma
  • CLL/SLL
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 11, 2023

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Nagoya, Aichi, Japan
  • +27 more
Nov 18, 2022

Lymphoma, B-Cell Trial in Belgium, France (Valemetostat tosylate)

Recruiting
  • Lymphoma, B-Cell
  • Valemetostat tosylate
  • Bruges, Belgium
  • +21 more
Jan 9, 2023

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Prostate Cancer Trial (Darolutamide Oral Tablet [Nubeqa])

Not yet recruiting
  • Prostate Cancer
  • Darolutamide Oral Tablet [Nubeqa]
  • (no location specified)
Jun 2, 2023

Advanced Follicular Lymphoma:Translational Study From FIL_FOLL12

Not yet recruiting
  • Follicular Lymphoma
  • EZH2 mutations/CNAs by droplet digital PCR (ddPCR)
  • EZH2-derived gene expression signature by RNA-Seq
  • Alessandria, Italy
  • +25 more
Apr 4, 2023

Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

Not yet recruiting
  • Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Tazverik (Tazemetostat)
  • (no location specified)
Oct 6, 2023

KRAS P.G12C Trial in Worldwide (D3S-001)

Recruiting
  • KRAS P.G12C
  • Detroit, Michigan
  • +12 more
Jan 16, 2023

Fasting Trial in Madrid (Fasting)

Enrolling by invitation
  • Fasting
  • Fasting
  • Madrid, Spain
    IMDEA Food
Jan 16, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Listening Effort Trial (Speech Enhancer)

Not yet recruiting
  • Listening Effort
  • Speech Enhancer
  • (no location specified)
Sep 14, 2023

Follicular Lymphoma Trial in United States (Tazemetostat, Rituximab)

Recruiting
  • Follicular Lymphoma
  • Birmingham, Alabama
  • +19 more
Mar 29, 2022

Urinary Stones Trial in United States (Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer, Standard Ureteroscopic

Recruiting
  • Urinary Stones
  • Ureteroscopy Laser Lithotripsy (URS-LL) with Acoustic Enhancer
  • Standard Ureteroscopic Laser Lithotripsy
  • Birmingham, Alabama
  • +26 more
Jan 4, 2023